Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
06/1999
06/16/1999CN1219928A Novel vitamin D analogues
06/16/1999CN1219924A Colchicine-skeleton compounds, their use as medicaments and compounds containing them
06/16/1999CN1219423A External- and thermal-mounted trauma medicinal powder bag
06/16/1999CN1219402A Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method
06/16/1999CN1219396A Gushifu-external application medicine for curing wind-cold syndrome
06/15/1999US5912360 Dioxolane intermediates
06/15/1999US5912346 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
06/15/1999US5912273 Triphenylethylenes compositions
06/15/1999US5912144 A polypeptide having an amino acid sequence for an immediate early response gene/g protein couplec receptor; anticarcinogenic, antiproliferative and antitumor agents
06/15/1999US5912014 Oral salmon calcitonin pharmaceutical products
06/15/1999CA2136821C Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
06/10/1999WO1999028493A2 Method for identifying inhibitors of g-protein coupled receptor hibef51
06/10/1999WO1999028454A1 An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
06/10/1999WO1999028444A1 Differentiation of adipose stromal cells into osteoblasts and uses thereof
06/10/1999WO1999028344A2 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
06/10/1999WO1999027890A2 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
06/10/1999WO1999007737A3 Lsr receptor, cloning and uses
06/10/1999CA2312847A1 Differentiation of adipose stromal cells into osteoblasts and uses thereof
06/10/1999CA2312009A1 An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
06/10/1999CA2309534A1 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
06/09/1999EP0921119A1 Pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them
06/09/1999EP0920867A1 Pyrido[2,3-a]pyrazine derivatives as PDE-IV and TNF inhibitors
06/09/1999EP0920863A1 2-Aryl-3-aroylbenzo(b)thiophenes useful for the treatment of estrogen deprivation syndrome
06/09/1999EP0920862A1 2-Arylbenzo b thiophenes useful for the treatment of estrogen deprivation syndrome
06/09/1999EP0920515A1 A NOVEL HUMAN mRNA EDITING ENZYME
06/09/1999EP0920507A2 Secreted proteins and polynucleotides encoding them
06/09/1999EP0920451A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
06/09/1999EP0920422A1 Crytalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
06/09/1999EP0920417A1 Il-8 receptor antagonists
06/09/1999EP0920330A1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS
06/09/1999EP0920309A1 Conjugated linoleic acid to maintain or enhance bone mineral content
06/09/1999EP0920308A1 Composition containing calcium, vitamin d and amino acids for treating osteoporosis and promoting bone fracture repair
06/09/1999EP0920306A2 Chemokine receptor antagonists and methods of use therefor
06/09/1999EP0920253A1 Il-8 receptor antagonists
06/09/1999EP0751932B1 Vitamin-d amide derivatives
06/09/1999EP0730598B1 Hindered esters of rapamycin and their use as pharmaceuticals
06/09/1999EP0614456B1 1alpha,24(s)-dihydroxy vitamin d2, its formation and use
06/09/1999CN1219166A Biphenylsulfonamide matrix metalloproteinase inhibitors
06/09/1999CN1219165A Tricyclic compounds having activity specific for integrins, particularly alpha v beta 3 integrins, method for preparing same
06/09/1999CN1218801A Tri-substituted imidazoles, and process of their preparation and using the same and having their pharmic composition
06/09/1999CN1218677A Bone activating and muscle strengthening pill
06/08/1999US5910437 Ligated d-protein of formula r-l-r' where r and r' are peptides and l is linking group of thiol ester or selenol ester; for production of chirally pure chemicals and drugs; production of racemic crystals; prolonged half-life in body
06/08/1999CA2242308A1 Novel compounds
06/03/1999WO1999027098A2 A-33 related antigens and their pharmacological uses
06/03/1999WO1999027077A1 Method for producing human intervertebral disc cells
06/03/1999WO1999026945A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS
06/03/1999WO1999026921A1 SUBSTITUTED β-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS
06/03/1999WO1999026650A1 ribB
06/03/1999WO1999026646A1 ribA
06/03/1999WO1999026631A1 Methods for treating postmenopausal women using ultra-low doses of estrogen
06/03/1999WO1999026616A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
06/03/1999WO1999010312B1 N-alkanoylphenylalanine derivatives
06/03/1999WO1999005096A3 Urokinase inhibitors
06/03/1999CA2311763A1 Method for producing human intervertebral disc cells
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/03/1999CA2309341A1 Substituted .beta.-alanine derivatives as cell adhesion inhibitors
06/03/1999CA2309204A1 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as .alpha.v.beta.3 antagonists
06/02/1999EP0919232A1 Composition for use in the treatment and prevention of hyperuricemia
06/02/1999EP0918860A2 Tumor necrosis factor-related polypeptide
06/02/1999EP0918792A1 Dipeptide benzamidine as a kininogenase inhibitor
06/02/1999EP0918771A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
06/02/1999EP0918746A1 Immunotherapeutic agents and their use in the reduction of cytokine levels
06/02/1999EP0918516A1 Methods of preventing skeletal problems in poultry
06/02/1999EP0845036B1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/02/1999EP0691849B1 Oesteoblast growth stimulating compostion containing pdgf and vitamin d
06/02/1999CN1218462A Crystalline (-)-3R, 4R-trans-7-methoxy-2,2-dimetnyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl) ethoxy] phenyl} chromane, hydrogen fumarate
06/02/1999CN1218409A Stimulation of host defence mechanisms against viral challenges
06/02/1999CN1218400A Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
06/02/1999CN1218047A Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
06/01/1999US5908863 Geminal carboxylic acids and esters thereof pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism
06/01/1999US5908858 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
06/01/1999US5908851 Derivatives of succinamide and their use as metalloproteinase inhibitor
06/01/1999US5908843 Thrombosis, antiinflammatory agent, arteriosclerosis, antitumor agents
05/1999
05/27/1999WO1999025813A1 Method for inducing osteoblast differentiation of human extramedullary adipose tissue cells
05/27/1999WO1999025725A1 NOVEL 19-NOR STEROIDS SUBSTITUTED IN POSITION 11β, PREPARATION METHOD AND INTERMEDIATES, APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
05/27/1999WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
05/27/1999WO1999025707A1 2-ARYLBENZO[b]THIOPHENES USEFUL FOR THE TREATMENT OF ESTROGEN DEPRIVATION SYNDROME
05/27/1999WO1999025706A1 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome
05/27/1999WO1999025697A1 Novel pyridazine derivatives and drugs containing the same as the active ingredient
05/27/1999WO1999025693A1 Metalloproteinase inhibitors
05/27/1999WO1999025687A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/27/1999WO1999025686A1 Cyclic amine derivatives and their use as drugs
05/27/1999WO1999025372A1 Small peptides and methods for treatment of asthma and inflammation
05/27/1999WO1999025344A1 Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
05/27/1999WO1999014346A3 SENSE mRNA THERAPY
05/27/1999WO1999012961A8 Estrogen receptor
05/27/1999WO1999010371A3 Cyclopeptide derivatives as adhesion inhibitors
05/27/1999CA2309859A1 2-arylbenzo¬b|thiophenes useful for the treatment of estrogen deprivation syndrome
05/27/1999CA2309824A1 2-aryl-3-aroylbenzo¬b|thiophenes useful for the treatment of estrogen deprivation syndrome
05/27/1999CA2309242A1 Novel 19-nor steroids substituted in position 11.beta., preparation method and intermediates, application as medicines and pharmaceutical compositions containing them
05/27/1999CA2306460A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/27/1999CA2303961A1 Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
05/26/1999EP0918059A1 Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
05/26/1999EP0917537A1 Novel parathyroid hormone-related peptide analogs
05/26/1999EP0917469A1 Methods for inducing bone formation
05/26/1999EP0772448A4 CYCLIC ANALOGS OF PTH AND PTHrP
05/26/1999CN1217197A Liniment for treating bony spur
05/26/1999CN1217190A Pill for improving appetite diminishing-stagnant of blood and removing obstruction in channels, and preparation method therefor
05/25/1999CA2011452C Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7–,17–)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn -3-one
05/20/1999WO1999024469A1 Secreted proteins and polynucleotides encoding them
1 ... 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 ... 820